-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
CNBX Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
- CNBX Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending August 31, 2024 was 30.2M shares, a 243% increase year-over-year.
- CNBX Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 30.2M shares, a 243% increase from 2023.
- CNBX Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 8.82M shares, a 622% increase from 2022.
- CNBX Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.22M shares, a 99.1% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)